Białecka, M.; Dziedziejko, V.; Safranow, K.; Krzystolik, A.; Marcinowska, Z.; Chlubek, D.; Rać, M.
Could Tumor Necrosis Factor Serve as a Marker for Cardiovascular Risk Factors and Left Ventricular Hypertrophy in Patients with Early-Onset Coronary Artery Disease? Diagnostics 2024, 14, 449.
https://doi.org/10.3390/diagnostics14040449
AMA Style
Białecka M, Dziedziejko V, Safranow K, Krzystolik A, Marcinowska Z, Chlubek D, Rać M.
Could Tumor Necrosis Factor Serve as a Marker for Cardiovascular Risk Factors and Left Ventricular Hypertrophy in Patients with Early-Onset Coronary Artery Disease? Diagnostics. 2024; 14(4):449.
https://doi.org/10.3390/diagnostics14040449
Chicago/Turabian Style
Białecka, Marta, Violetta Dziedziejko, Krzysztof Safranow, Andrzej Krzystolik, Zuzanna Marcinowska, Dariusz Chlubek, and Monika Rać.
2024. "Could Tumor Necrosis Factor Serve as a Marker for Cardiovascular Risk Factors and Left Ventricular Hypertrophy in Patients with Early-Onset Coronary Artery Disease?" Diagnostics 14, no. 4: 449.
https://doi.org/10.3390/diagnostics14040449
APA Style
Białecka, M., Dziedziejko, V., Safranow, K., Krzystolik, A., Marcinowska, Z., Chlubek, D., & Rać, M.
(2024). Could Tumor Necrosis Factor Serve as a Marker for Cardiovascular Risk Factors and Left Ventricular Hypertrophy in Patients with Early-Onset Coronary Artery Disease? Diagnostics, 14(4), 449.
https://doi.org/10.3390/diagnostics14040449